Top 10 Companies in the (S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) Market (2026): Market Leaders Powering Global Pharmaceutical Supply

MARKET INSIGHTS

Global (S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) market size was valued at USD 245.6 million in 2025. The market is projected to grow from USD 261.8 million in 2026 to USD 498.3 million by 2034, exhibiting a CAGR of 8.4% during the forecast period.

(S)-1-Phenyl-1,2-ethanediol is a chiral diol compound widely recognized for its role as a key building block in asymmetric synthesis and pharmaceutical manufacturing. Characterized by its high enantiomeric purity, this compound serves as a critical chiral intermediate in the production of active pharmaceutical ingredients (APIs), agrochemicals, and fine chemicals. Its stereospecific properties make it particularly valuable in enantioselective reactions, where precise molecular configuration directly influences the therapeutic efficacy of end products.

The market is gaining momentum driven by the expanding demand for enantiomerically pure compounds in drug development, growing investments in chiral chemistry, and the rising adoption of green synthesis methodologies. Furthermore, the increasing prevalence of chronic diseases requiring stereospecific drug formulations continues to accelerate demand across global pharmaceutical supply chains. Key producers and specialty chemical companies are actively expanding their chiral intermediate portfolios to meet this evolving demand landscape.

(S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) Market – View in Detailed Research Report

Top 10 Companies in the (S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) Market

10️⃣ 1. Hairui Fine Chemicals Co., Ltd.

Headquarters: China
Key Offering: High enantiomeric excess (≥98%) (S)-1-Phenyl-1,2-ethanediol for API synthesis

Hairui Fine Chemicals has established a robust asymmetric synthesis platform enabling scalable production of enantiopure diols. Their processes leverage chiral organocatalysts and biocatalytic steps, delivering consistent optical purity across large batches. The company serves major CDMOs and pharmaceutical manufacturers, ensuring compliance with GMP and ICH Q6A guidelines.

Sustainability & Growth Initiatives:

• Investment in continuous‑flow asymmetric reduction to reduce waste.
• Partnerships with leading pharma to co‑develop green routes.
• Expansion of production capacity in Shanghai and Shenzhen.

10️⃣ 2. Capot Chemical Co., Ltd.

Headquarters: China
Key Offering: GMP‑compliant (S)-1-Phenyl-1,2-ethanediol with >99% ee for late‑stage synthesis

Capot Chemical focuses on high‑purity chiral intermediates for pharmaceutical and fine‑chemical sectors. Their state‑of‑the‑art chiral resolution units provide rapid scale‑up while maintaining stringent quality control, making them a preferred supplier for contract manufacturers.

Sustainability & Growth Initiatives:

• Implementation of renewable energy sources in manufacturing facilities.
• Development of solvent‑free biocatalytic processes.
• Strategic alliances with CDMOs to expand global reach.

10️⃣ 3. Finetech Industry Limited

Headquarters: China
Key Offering: Customized chiral diol solutions for R&D and pilot‑scale production

Finetech Industry offers flexible batch sizes and rapid turnaround, catering to academic and industrial research. Their proprietary chiral catalysts enable efficient asymmetric reductions with high ee.

Sustainability & Growth Initiatives:

• Adoption of green chemistry metrics to track carbon footprint.
• Investment in modular, scalable reactors.
• Collaboration with universities for catalyst development.

10️⃣ 4. Ningbo Inno Pharmchem Co., Ltd.

Headquarters: China
Key Offering: High‑purity (S)-1-Phenyl-1,2-ethanediol for API intermediates and specialty chemicals

Inno Pharmchem specializes in integrated synthesis and purification, ensuring consistent enantiomeric excess. Their quality management system aligns with international GMP standards.

Sustainability & Growth Initiatives:

• Optimization of reaction conditions to minimize waste.
• Implementation of closed‑loop recycling of solvents.
• Expansion of product portfolio into agrochemical intermediates.

10️⃣ 5. Biosynth AG

Headquarters: Switzerland
Key Offering: Research‑grade chiral diols with customizable purity levels

Biosynth AG delivers high‑quality chiral intermediates for academic and early‑stage pharma projects. Their flexible synthesis routes accommodate a range of batch sizes and purity specifications.

Sustainability & Growth Initiatives:

• Use of biocatalysts for eco‑friendly production.
• Carbon‑neutral manufacturing facilities.
• Partnerships with biotech firms for novel chiral ligand development.

10️⃣ 6. Tokyo Chemical Industry Co., Ltd.

Headquarters: Japan
Key Offering: High‑purity (S)-1-Phenyl-1,2-ethanediol for fine‑chemical and pharmaceutical applications

Tokyo Chemical Industry leverages advanced chiral resolution technologies to provide consistent enantiomeric excess. Their robust quality assurance programs satisfy the most stringent regulatory requirements.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient manufacturing processes.
• Development of low‑solvent synthesis routes.
• Expansion into specialty materials and polymer science.

10️⃣ 7. Enamine Ltd.

Headquarters: Ukraine
Key Offering: Research‑grade chiral diols with rapid supply for academic projects

Enamine provides a wide range of chiral intermediates, including (S)-1-Phenyl-1,2-ethanediol, with fast delivery times and flexible batch sizes suitable for research laboratories.

Sustainability & Growth Initiatives:

• Use of renewable feedstocks for synthesis.
• Investment in digital supply chain management.
• Collaboration with global CDMOs to enhance market reach.

10️⃣ 8. Ambeed Inc.

Headquarters: United States
Key Offering: Ultra‑high purity (S)-1-Phenyl-1,2-ethanediol for late‑stage API synthesis

Ambeed focuses on delivering the highest optical purity for critical drug development stages. Their small‑batch, high‑quality approach is ideal for specialty pharma and niche markets.

Sustainability & Growth Initiatives:

• Adoption of green chemistry principles across all processes.
• Continuous improvement of waste‑reduction protocols.
• Strategic alliances with U.S. CDMOs to support domestic manufacturing.

10️⃣ 9. Hunan Aslsen Technology Co., Ltd.

Headquarters: China
Key Offering: Custom chiral diol synthesis for pilot‑scale and scale‑up projects

Hunan Aslsen Technology offers tailored synthesis solutions, providing rapid prototyping and scale‑up for both research and commercial applications.

Sustainability & Growth Initiatives:

• Implementation of energy‑efficient reactors.
• Development of solvent‑free reaction pathways.
• Expansion of production capacity to meet growing demand.

10️⃣ 10. Shanghai Qixuan Biotech Co., Ltd.

Headquarters: China
Key Offering: High‑purity (S)-1-Phenyl-1,2-ethanediol for fine‑chemical and pharmaceutical intermediates

Shanghai Qixuan Biotech specializes in scalable production of chiral diols, integrating advanced chromatographic separation for optimal purity.

Sustainability & Growth Initiatives:

• Use of renewable energy in manufacturing.
• Investment in continuous‑flow synthesis to reduce process time.
• Partnerships with CDMOs to expand global footprint.

Download FREE Sample Report: (S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) Market – View in Detailed Research Report

Get Full Report: (S)-1-Phenyl-1,2-ethanediol (CAS 25779-13-9) Market – View in Detailed Research Report

Market Outlook

The forecast period from 2026 to 2034 will see the (S)-1-Phenyl-1,2-ethanediol market expand at a steady CAGR of 8.4%, driven by the growth of the global pharmaceutical and fine‑chemical sectors. Key growth drivers include the increasing adoption of chiral switching in drug development, rising investment in green and asymmetric synthesis, and the expansion of generic pharmaceutical manufacturing in emerging markets.

Emerging Trends

Future trends point toward greater integration of biocatalytic routes, continuous‑flow manufacturing, and the development of chiral polymer and liquid‑crystal materials. The market will also see increased focus on sustainability, with manufacturers adopting renewable feedstocks and energy‑efficient processes to meet regulatory and consumer demands.